FIG. 2.
Frequency of moderate and severe VMS per 24 hours with fezolinetant BID (A) or Fezolinetant QD dosing (B), Full analysis set. F/U, follow-up; VMS, vasomotor symptoms. aBaseline is the average frequency of 24-hour VMS from seven nonmissing days before day 1.